IDiyas

For the Inventor, By the Inventor

Terhagen, Belgium

Piet Tom Bert Paul Wigerinck

USPTO Granted Patents = 24 

 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 65(Granted Patents)


Location History:

  • Vosselaar, BE (2002 - 2005)
  • Vosselaan, BE (2005 - 2008)
  • Terhagen, BE (2007 - 2020)

Company Filing History:

goldMedal12 out of 66 
 
Tibotec Pharmaceuticals Ltd.
 patents
silverMedal5 out of 2,076 
 
Janssen Pharmaceutica Nv
 patents
bronzeMedal4 out of 45 
 
Janssen R&d Ireland
 patents
4. 1 out of 13 
 
Tibotec Bvba
 patents
5. 1 out of 111 
 
Janssen Sciences Ireland Uc
 patents
6. 1 out of 60 
 
Janssen Sciences Ireland Unlimited Company
 patents

Years Active: 2002-2020

Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents
1. 10858369 - Pseudopolymorphic forms of a HIV protease inhibitor (2020-12-08),
2. 10000504 - Pseudopolymorphic forms of a HIV protease inhibitor (2018-06-19),
3. 8580981 - Process for the preparation of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate (2013-11-12),
4. 8557854 - Use of a sulfonamide compound for improving the pharmacokinetics of a drug (2013-10-15),
5. 8518987 - Pseudopolymorphic forms of a HIV protease inhibitor (2013-08-27),
6. 8268885 - Entry inhibitors of the HIV virus (2012-09-18),
7. 8143421 - Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors (2012-03-27),
8. 8119801 - HIV inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines (2012-02-21),
9. 8084494 - Substituted aminophenylsulfonamide compounds as HIV protease inhibitor (2011-12-27),
10. 7935711 - HIV inhibiting 2-(4-cyanophenylamino) pyrimidine oxide derivatives (2011-05-03),
11. 7803836 - Aminophenylsulfonamide derivatives as HIV protease inhibitor (2010-09-28),
12. 7772411 - Process for the preparation of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate (2010-08-10),
13. 7745432 - (1,10b-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo[1,5 C][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors (2010-06-29),
14. 7659404 - Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors (2010-02-09),
15. 7622582 - Derivatives of 1-phenyl-benzofuro[3,2]pyridin-2(1H)-one (2009-11-24),

Title: Piet Tom Bert Paul Wigerinck: A Trailblazer in Innovation and Invention

Introduction:

Throughout his illustrious career, Piet Tom Bert Paul Wigerinck has emerged as a visionary inventor, renowned for his exceptional creativity and ingenuity. Hailing from Terhagen, Belgium, Wigerinck has marked his name in the annals of innovation with a total of 24 patents. This article delves into his latest patents, career highlights, notable collaborations, and the lasting impact he has made in diverse industries.

Latest Patents:

Wigerinck's latest patents showcase his expertise in the field of pharmaceutical research. He has developed new pseudopolymorphic forms of a HIV protease inhibitor, specifically (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3-[[(4-aminophenyl) sulfonyl] isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate. These patents not only underscore his innovative solutions but also demonstrate his dedication to advancing healthcare and combating global health challenges.

Career Highlights:

Wigerinck has crafted an impressive career trajectory, leaving a lasting impact on various industries. Notably, he has held significant positions at Tibotec Pharmaceuticals Ltd. and Janssen Pharmaceutica Nv. During his tenure, Wigerinck has consistently pushed the boundaries of scientific exploration, leading to breakthroughs that have revolutionized the pharmaceutical landscape. His ability to combine scientific knowledge with an entrepreneurial spirit has allowed him to shape the future of healthcare through his groundbreaking inventions.

Collaborations:

Wigerinck's contributions extend beyond his individual brilliance, as he has actively engaged in collaborations with esteemed colleagues. Among his notable coworkers are Dominique Louis Nestor Ghislain Surleraux and Herman Augustinus De Kock. Together, this formidable team has synergized their expertise, working towards shared goals and collectively driving innovation in their respective fields. Collaboration has been a cornerstone of Wigerinck's success, allowing him to tap into a rich pool of knowledge and expertise to bring his remarkable inventions to life.

Conclusion:

Piet Tom Bert Paul Wigerinck's career exemplifies the power of innovation and inventive thinking. With an impressive portfolio of 24 patents, he has continually pushed the boundaries of scientific discovery in the pharmaceutical industry. His latest patents, focusing on novel forms of a HIV protease inhibitor, underscore his commitment to addressing pressing global health challenges. Collaborating with notable colleagues has further amplified the impact of his work, reaffirming his status as a trailblazer in innovation. Wigerinck's inventive spirit and unwavering dedication continue to shape the future, inspiring the next generation of inventors and innovators.

For more information on innovators, patents, and groundbreaking inventions, kindly visit our website: idiyas.com.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…